141 related articles for article (PubMed ID: 32962616)
1. Exploring μ-Opioid Receptor Splice Variants as a Specific Molecular Target for New Analgesics.
Mizoguchi H; Fujii H
Curr Top Med Chem; 2020; 20(31):2866-2877. PubMed ID: 32962616
[TBL] [Abstract][Full Text] [Related]
2. Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.
Lu Z; Xu J; Rossi GC; Majumdar S; Pasternak GW; Pan YX
J Clin Invest; 2015 Jul; 125(7):2626-30. PubMed ID: 26011641
[TBL] [Abstract][Full Text] [Related]
3. Truncated μ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia.
Lu Z; Xu J; Xu M; Rossi GC; Majumdar S; Pasternak GW; Pan YX
Anesth Analg; 2018 Mar; 126(3):1050-1057. PubMed ID: 28991118
[TBL] [Abstract][Full Text] [Related]
4. Lack of a rewarding effect and a locomotor-enhancing effect of the selective μ-opioid receptor agonist amidino-TAPA.
Mizoguchi H; Watanabe C; Osada S; Yoshioka M; Aoki Y; Natsui S; Yonezawa A; Kanno S; Ishikawa M; Sakurada T; Sakurada S
Psychopharmacology (Berl); 2010 Oct; 212(2):215-25. PubMed ID: 20683583
[TBL] [Abstract][Full Text] [Related]
5. Broad-spectrum analgesic efficacy of IBNtxA is mediated by exon 11-associated splice variants of the mu-opioid receptor gene.
Wieskopf JS; Pan YX; Marcovitz J; Tuttle AH; Majumdar S; Pidakala J; Pasternak GW; Mogil JS
Pain; 2014 Oct; 155(10):2063-70. PubMed ID: 25093831
[TBL] [Abstract][Full Text] [Related]
6. Tetrapeptide Endomorphin Analogs Require Both Full Length and Truncated Splice Variants of the Mu Opioid Receptor Gene Oprm1 for Analgesia.
Marrone GF; Lu Z; Rossi G; Narayan A; Hunkele A; Marx S; Xu J; Pintar J; Majumdar S; Pan YX; Pasternak GW
ACS Chem Neurosci; 2016 Dec; 7(12):1717-1727. PubMed ID: 27648914
[TBL] [Abstract][Full Text] [Related]
7. Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene,
Liu S; Kang WJ; Abrimian A; Xu J; Cartegni L; Majumdar S; Hesketh P; Bekker A; Pan YX
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680158
[TBL] [Abstract][Full Text] [Related]
8. Mu Opioid Pharmacology: 40 Years to the Promised Land.
Pasternak GW
Adv Pharmacol; 2018; 82():261-291. PubMed ID: 29413524
[TBL] [Abstract][Full Text] [Related]
9. Mu Opioids Induce Biased Signaling at the Full-Length Seven Transmembrane C-Terminal Splice Variants of the mu Opioid Receptor Gene, Oprm1.
Narayan A; Hunkele A; Xu J; Bassoni DL; Pasternak GW; Pan YX
Cell Mol Neurobiol; 2021 Jul; 41(5):1059-1074. PubMed ID: 33033993
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm.
Pan L; Xu J; Yu R; Xu MM; Pan YX; Pasternak GW
Neuroscience; 2005; 133(1):209-20. PubMed ID: 15893644
[TBL] [Abstract][Full Text] [Related]
11. Involvement of mouse μ-opioid receptor splice variants in the spinal antinociception induced by the dermorphin tetrapeptide analog amidino-TAPA.
Mizoguchi H; Watanabe C; Higashiya T; Takeda S; Moriyama K; Yonezawa A; Sato T; Komatsu T; Sakurada T; Sakurada S
Eur J Pharmacol; 2011 Jan; 651(1-3):66-72. PubMed ID: 21047509
[TBL] [Abstract][Full Text] [Related]
12. Distinct physiological role of amidino-TAPA-sensitive and DAMGO-insensitive μ-opioid receptor splice variants in the mouse spinal cord.
Mizoguchi H; Watanabe C; Higashiya T; Takeda S; Moriyama K; Aoki Y; Kon-no T; Takagi H; Yonezawa A; Sato T; Sakurada T; Sakurada S
Eur J Pharmacol; 2013 Jul; 711(1-3):80-6. PubMed ID: 23623932
[TBL] [Abstract][Full Text] [Related]
13. Genetic dissociation of morphine analgesia from hyperalgesia in mice.
Marrone GF; Le Rouzic V; Varadi A; Xu J; Rajadhyaksha AM; Majumdar S; Pan YX; Pasternak GW
Psychopharmacology (Berl); 2017 Jun; 234(12):1891-1900. PubMed ID: 28343361
[TBL] [Abstract][Full Text] [Related]
14. Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.
Majumdar S; Grinnell S; Le Rouzic V; Burgman M; Polikar L; Ansonoff M; Pintar J; Pan YX; Pasternak GW
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19778-83. PubMed ID: 22106286
[TBL] [Abstract][Full Text] [Related]
15. Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene,
Kang W; Liu S; Xu J; Abrimian A; Malik AF; Chien R; Adaralegbe A; Amponsah A; Cartegni L; Pintar J; Pan YX
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328429
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of the murine mu opioid receptor: increased complexity of Oprm gene splicing.
Kvam TM; Baar C; Rakvåg TT; Kaasa S; Krokan HE; Skorpen F
J Mol Med (Berl); 2004 Apr; 82(4):250-5. PubMed ID: 14991152
[TBL] [Abstract][Full Text] [Related]
17. The pharmacology of mu analgesics: from patients to genes.
Pasternak GW
Neuroscientist; 2001 Jun; 7(3):220-31. PubMed ID: 11499401
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into mu opioid pharmacology: From the clinic to the bench.
Pasternak GW
Clin J Pain; 2010 Jan; 26 Suppl 10(Suppl 10):S3-9. PubMed ID: 20026962
[TBL] [Abstract][Full Text] [Related]
19. Truncated mu opioid GPCR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS.
Marrone GF; Grinnell SG; Lu Z; Rossi GC; Le Rouzic V; Xu J; Majumdar S; Pan YX; Pasternak GW
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3663-8. PubMed ID: 26976581
[TBL] [Abstract][Full Text] [Related]
20. New vistas in opioid control of pain.
Mizoguchi H; Watanabe C; Sakurada T; Sakurada S
Curr Opin Pharmacol; 2012 Feb; 12(1):87-91. PubMed ID: 22104733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
